abstract |
The invention relates to novel insulin analogs with a baseline time / action profile, characterized by the addition and / or substitution of negatively and positively charged amino acid residues, and an amidation of the C-terminal carboxy group of the B chain and histidine. at position 8 of insulin chain A, its preparation and use. |